|
Volumn 19, Issue 1, 1998, Pages 5-8
|
Endothelin: New discoveries and rapid progress in the clinic
a b c d |
Author keywords
[No Author keywords available]
|
Indexed keywords
3 (2 CARBOXYMETHOXY 4 METHOXYPHENYL) 1 (3,4 METHYLENEDIOXYPHENYL) 5 PROPOXY 2 INDANCARBOXYLIC ACID;
ATRASENTAN;
BOSENTAN;
CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL);
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ENDOTHELIN 1;
ENDOTHELIN 2;
ENDOTHELIN A RECEPTOR ANTAGONIST;
ENDOTHELIN B RECEPTOR ANTAGONIST;
ENDOTHELIN CONVERTING ENZYME;
ENDOTHELIN RECEPTOR;
ENDOTHELIN RECEPTOR ANTAGONIST;
N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE;
NITRIC OXIDE;
PROSTACYCLIN;
TAK 044;
AMINO ACID SUBSTITUTION;
CARDIOVASCULAR DISEASE;
CELLULAR DISTRIBUTION;
CONFERENCE PAPER;
CONGESTIVE HEART FAILURE;
HEART VENTRICLE ARRHYTHMIA;
HUMAN;
HYPERTENSION;
INTRAVENOUS DRUG ADMINISTRATION;
KIDNEY DISEASE;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
PRIORITY JOURNAL;
PULMONARY HYPERTENSION;
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;
SITE DIRECTED MUTAGENESIS;
VASCULAR ENDOTHELIUM;
VASOCONSTRICTION;
VASODILATATION;
|
EID: 0031905118
PISSN: 01656147
EISSN: None
Source Type: Journal
DOI: 10.1016/S0165-6147(97)01144-9 Document Type: Conference Paper |
Times cited : (136)
|
References (15)
|